Table III.
Comparison of abdominal US, CECT and DWIBS/T2 findings.
| Patient number | Final diagnosis | Stagea | Abdominal US | CECT | DWIBS/T2 |
|---|---|---|---|---|---|
| 1 | Hepatocellular carcinoma | T3a | (+) | (+) | (+) |
| 2 | Hepatocellular carcinoma | T2 | (+) | (+) | (+) |
| 3 | Hepatocellular carcinoma | T3b | (+) | (+) | (+) |
| 4 | Hepatocellular carcinoma | T3b | (+) | (+) | (+) |
| 5 | Hepatocellular carcinoma | T2 | (+) | (+) | (+) |
| 6 | Metastatic liver cancer | NA | (+) | (+) | (+) |
| 7 | Metastatic liver cancer | NA | (+) | (+) | (+) |
| 8 | Metastatic liver cancer | NA | (+) | (+) | (+) |
| 9 | Metastatic liver cancer | NA | (+) | (+) | (+) |
| 10 | Pancreatic cancer | T3 | (+) | (+) | (+) |
| 11 | Pancreatic cancer | T4 | (+) | (+) | (+) |
| 12 | Pancreatic cancer | T3 | (−) | (+) | (+) |
| 13 | Renal cell carcinoma | T1b | (+) | (+) | (+) |
| 14 | Malignant lymphoma | NA | (+) | (+) | (+) |
a
American joint committee on cancer classification (7th edition). US, abdominal ultrasound; CECT, contrast-enhanced computed tomography; DWIBS/T2, diffusion-weighted whole-body imaging with background body signal suppression T2-weighted image fusion; (+), positive results; (−), negative results; NA, not applicable.